Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-04

ALLO vs TECX: stock comparison and AI forecast

Allogene Therapeutics, Inc. (ALLO) and Tectonic Therapeutic, Inc. (TECX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Biological Products, (No Diagnostic Substances)

ALLO Allogene Therapeutics, Inc.

Price
$1.12 -48.4% · 6M
Market Cap
$387M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Biological Products, (No Diagnostic Substances)

TECX Tectonic Therapeutic, Inc.

Price
$18.98 -36.0% · 6M
Market Cap
$371M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-05-05 → 2026-11-03

Six-month price performance

Closing prices rebased to 100 at the start of the window.

6080100120
ALLO -48.4% TECX -36.0%
ALLO · TECX

Key facts

  • ALLO and TECX have similar market capitalizations ($387M and $371M).
  • Over the last six months TECX returned -36.0% and ALLO -48.4%.
  • ALLO carries 0.26 times debt per unit of equity, against 0.06 times for TECX.
  • Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricALLOTECX
Market Cap$387M$371M
P/B Ratio0.89x1.66x
EPS$-0.77$-5.50
Book Value/Share$1.26$11.45
FCF/Share$-0.30$-3.70

Profitability & Margins

MetricALLOTECX
ROE-37.9%-38.3%
ROA-30.1%-36.2%
ROIC-34.8%-41.9%
Operating Margin-3886.1%–
Net Margin-3566.7%–
EBT Margin-3489.0%–
Tax Rate–-1.5%

Financial Health

MetricALLOTECX
Current Ratio10.72x22.29x
D/E Ratio0.26x0.06x
Financial Leverage1.26x1.06x
Interest Coverage-6.6x1728.7x
Working Capital$308M$221M

Cash Flow

MetricALLOTECX
Operating Cash Flow-$102M-$72M
Free Cash Flow-$103M-$72M
Capital Spending-$400K-$280K

Operational Efficiency

MetricALLOTECX
Payables Period–-4 days

Income Statement

MetricALLOTECX
Operating Income-$180M-$95M
Net Income-$165M-$86M
R&D Expense$123M$72M
Cost of Goods Sold–-$167M

Dividend & Shareholder Information

MetricALLOTECX
Shares Outstanding345M20M
FAQ

ALLO vs TECX: stock comparison and AI forecast

Which is bigger, ALLO or TECX?

ALLO and TECX have similar market capitalizations ($387M and $371M).

Which stock performed better over the last six months, ALLO or TECX?

Over the last six months TECX returned -36.0% and ALLO -48.4%.

Which one does Intratio's AI model rank higher, ALLO or TECX?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.